Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC). [electronic resource]
- BJU international Jul 2015
- 17-29 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
1464-410X
10.1111/bju.12867 doi
Antineoplastic Agents--administration & dosage Antineoplastic Combined Chemotherapy Protocols--therapeutic use Biomarkers, Tumor Humans Male Neoplasm Metastasis Prostatic Neoplasms, Castration-Resistant--drug therapy Time Factors Treatment Outcome